ArticleCardio-oncology (London, England)2025
Machine learning for cardio-oncology: predicting global longitudinal strain from conventional echocardiographic measurements in cancer patients.
Article in Cardio-oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- External validation of machine learning models predicting global longitudinal strain from conventional echocardiography in patients with cancer.The international journal of cardiovascular imaging · 2026Article
- Electrical risk score and electrocardiographic markers in acute cholecystitis: a prospective cross-sectional study using explainable machine learning.BMC cardiovascular disorders · 2026Article
- Correction: Machine learning for cardio-oncology: predicting global longitudinal strain from conventional echocardiographic measurements in cancer patients.Cardio-oncology (London, England) · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGlobal longitudinal strain (GLS) is an important prognostic indicator for predicting heart failure and cancer therapy-related cardiac dysfunction (CTRCD). Although access to GLS measurement has increased across institutions, its actual use in clinical practice remains limited due to practical barriers such as limited time and insufficient training. If reduced GLS could be predicted from conventional echocardiographic parameters, it could help identify patients who would most benefit from direct GLS assessment. Therefore, in this study, we tested the hypothesis that reduced GLS can be predicted from conventional echocardiography via a machine learning (ML) approach.
methodsThis single-center cross-sectional study included patients who visited the Tokyo Metropolitan Tama Medical Center Hospital and underwent echocardiography with GLS before or after anticancer chemotherapy. Low-GLS was defined as a GLS < 16; otherwise, it was defined as Normal-GLS. Patients with EF < 50% were excluded. We developed ML models that predict Low-GLS from conventional echocardiography measurements. Sixteen ML models were constructed including various boosting and tree-based methods. We assessed the models by the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, Positive predictive value (PPV), Negative predictive value (NPV), and F1 score. The Shapley Additive exPlanations (SHAP) method was employed to evaluate the essential predictors.
resultsA total of 1,484 patients (64 ± 13 years old, 69% female) were enrolled for ML model development, including 406 patients with Low-GLS and 1,078 with Normal-GLS. The best model for the test dataset was the CatBoost classifier (AUC, 0.748; accuracy, 0.734). Diastolic dysfunction indices [such as septal/lateral mitral annular early diastolic velocity (e') and E-wave to atrial contraction filling velocity (E/A)] and peak velocity‑related parameters [aortic valve peak velocity (AV-Vmax) and left ventricular outflow tract velocity maximum (LVOT-Vmax)] played essential roles in the Low-GLS prediction model.
conclusionThis study indicated the possibility that Low-GLS might be predicted by machine learning models from conventional echocardiography measurements in cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.